BICYCLE THERAPEUTICS PLC-ADR (BCYC) Stock Balance Sheet
NASDAQ:BCYC • US0887861088
Current stock price
5.33 USD
+0.19 (+3.7%)
At close:
5.3442 USD
+0.01 (+0.27%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 628.11M | 879.52M | 526.42M | 339.20M | 438.70M | |||
| Receivables | 35.59M | 35.65M | 24.04M | 21.20M | 11.90M | |||
| Other Current Assets | 19.18M | 13.43M | 11.41M | 9.00M | 8.00M | |||
| Total Current Assets | 682.88M | 928.61M | 561.87M | 369.40M | 458.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 21.91M | 17.19M | 27.68M | 32.80M | 17.80M | |||
| Other Non-Current Assets | 12.80M | 11.07M | 5.79M | 8.50M | 3.40M | |||
| Total Non-Current Assets | 34.71M | 28.26M | 33.48M | 41.20M | 21.20M | |||
| TOTAL ASSETS | 717.60M | 956.87M | 595.34M | 410.60M | 479.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 205.00K | 175.00K | N/A | N/A | N/A | |||
| Accrued Expenses | 44.01M | 40.77M | 31.25M | 25.00M | 13.70M | |||
| Accounts Payable | 9.67M | 15.79M | 13.05M | 6.50M | 2.70M | |||
| Other Current Liabilities | 3.10M | 10.49M | 25.23M | 21.90M | 19.80M | |||
| Total Current Liabilities | 56.98M | 67.23M | 69.54M | 53.30M | 36.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 669.00K | 0.00 | 30.70M | 30.30M | 29.90M | |||
| Other Non-Current Liabilities | 49.97M | 96.58M | 124.18M | 56.20M | 67.40M | |||
| Total Non-Current Liabilities | 50.64M | 96.58M | 154.88M | 86.50M | 97.30M | |||
| TOTAL LIABILITIES | 107.62M | 163.81M | 224.41M | 139.80M | 133.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -899.75M | -680.79M | -511.76M | -331.10M | -218.40M | |||
| Additional Paid In Capital | 1.51B | 1.47B | 883.45M | 601.10M | 567.60M | |||
| Common Shares | 894.00K | 890.00K | 550.00K | 400.00K | 400.00K | |||
| Other Shareholders' Equity | -3.50M | 119.00K | -1.30M | 400.00K | -3.40M | |||
| Shares Outstanding | 69.71M | 69.40M | 42.64M | 30.05M | 29.75M | |||
| Tangible Book Value per Share | 8.79 | 11.48 | 8.74 | 9.06 | 11.70 | |||
| Total Shareholders' Equity | 609.98M | 793.06M | 370.93M | 270.80M | 346.30M | |||
| TOTAL LIABILITIES AND EQUITY | 717.60M | 956.87M | 595.34M | 410.60M | 479.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | N/A | 0.08 | 0.11 | 0.09 | |||
| Current Ratio | 11.98 | 13.81 | 8.08 | 6.93 | 12.67 | |||
| Return On Assets (ROA) | -30.51% | -17.67% | -30.35% | -27.45% | -13.93% | |||
| Return On Equity (ROE) | -35.90% | -21.31% | -48.71% | -41.62% | -19.30% | |||
All data in USD , ROIC based on taxRate of 0.21